Apotex Slams Merck's Nasonex Generic Suit As Redundant
Apotex Inc. on Monday urged a New Jersey federal court to dismiss Merck Sharp & Dohme Corp.'s second suit accusing the Canadian drugmaker of infringing a Nasonex spray patent by moving...To view the full article, register now.
Already a subscriber? Click here to view full article